U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07141511) titled 'A Study to Investigate the Relative Bioavailability and Food Effect of a Fixed-Dose Combination Tablet Containing Zanubrutinib and Sonrotoclax (BG-71332) in Healthy Adults' on Aug. 19.
Brief Summary: The purpose of this study is to evaluate the relative bioavailability of a fixed-dose combination tablet containing zanubrutinib and sonrotoclax (BG-71332) compared to a zanubrutinib capsule and sonrotoclax tablet administered simultaneously and the effect of food on how the body processes the fixed-dose combination tablet.
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers
Intervention:
DRUG: B...